(AP) _ Talis Biomedical Corp. (TLIS) on Tuesday reported a loss of $60.5 million in its first quarter. On a per-share basis, the Menlo Park, California- ...
News
- Talis: Q1 Earnings Snapshot
- Vascular Biogenics: Q1 Earnings Snapshot
The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share. The gene therapy biotech company ...
- FibroGen: Q1 Earnings Snapshot
The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 90 cents per share. The biotech drug developer ...
- Six Ways to Get Your Mind "Unstuck" While Your Body May be Stuck at Home
... University of Texas Health at San Antonio and in public health and health sciences at Los Angeles Pacific University. He holds a Ph.D. in biomedical sciences and medical physiology and an MPH in chronic disease epidemiology.
- Cara: Q1 Earnings Snapshot
The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 62 cents per share. The biotechnology company posted ...